Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Blood pressure changes with once-weekly semaglutide 7.2 mg in adults with obesity: post hoc analysis of the STEP UP randomised, controlled trial 

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress short oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)